APA (7th ed.) Citation

Q, L., C, M., F, W., L, L., G, X., Z, L., . . . W, C. (2026). Efficacy and Safety of SPH3127 Tablet, a Novel Direct Renin Inhibitor, in Patients with Mild-to-Moderate Essential Hypertension: A Phase III Randomised Trial. Drugs, 86(7), 1121. https://doi.org/10.1007/s40265-026-02315-z

Chicago Style (17th ed.) Citation

Q, Lv, et al. "Efficacy and Safety of SPH3127 Tablet, a Novel Direct Renin Inhibitor, in Patients with Mild-to-Moderate Essential Hypertension: A Phase III Randomised Trial." Drugs 86, no. 7 (2026): 1121. https://doi.org/10.1007/s40265-026-02315-z.

MLA (9th ed.) Citation

Q, Lv, et al. "Efficacy and Safety of SPH3127 Tablet, a Novel Direct Renin Inhibitor, in Patients with Mild-to-Moderate Essential Hypertension: A Phase III Randomised Trial." Drugs, vol. 86, no. 7, 2026, p. 1121, https://doi.org/10.1007/s40265-026-02315-z.